Antiviral Agents/therapeutic use; Azetidines/therapeutic use; COVID-19 Drug Treatment; Purines/therapeutic use; Pyrazoles/therapeutic use; Sulfonamides/therapeutic use; Adenosine Monophosphate/analogs & derivatives; Adenosine Monophosphate/therapeutic use; Adult; Aged; Alanine/analogs & derivatives; Alanine/therapeutic use; Antiviral Agents/administration & dosage; Antiviral Agents/adverse effects; Azetidines/administration & dosage; Azetidines/adverse effects; Child; Drug Approval; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Purines/administration & dosage; Purines/adverse effects; Pyrazoles/administration & dosage; Pyrazoles/adverse effects; Randomized Controlled Trials as Topic; Sulfonamides/administration & dosage; Sulfonamides/adverse effects; United States; United States Food and Drug Administration

COVID-19; Oluminat; Veklury; adverse effects; baricitinib; coronavirus; dosage; drug interactions; efficacy; remdesivir; safety